Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
| Brand name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Generic name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Active ingredient(s) | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Distributed by / for | Avet Pharmaceuticals Inc., East Brunswick, NJ 08816 |
| NDC | 23155-603-51 |
| Full product label | CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51 |
| Recalling firm | Heritage Pharmaceuticals Inc |
| Distribution | Nationwide within the U.S |
| Recall initiated | 2026-07-30 |
| Report date | 2026-08-19 |
| Recall completed | — |
| Recall number | D-0768-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | East Brunswick NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗